We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$591B
AUM Growth
-$94.6B
Cap. Flow
+$3.09B
Cap. Flow %
0.52%
Top 10 Hldgs %
20.46%
Holding
2,656
New
75
Increased
1,551
Reduced
819
Closed
97

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.72B
2
BKNG icon
Booking.com
BKNG
+$2.61B
3
RHT
Red Hat Inc
RHT
+$1.62B
4
JPM icon
JPMorgan Chase
JPM
+$1.43B
5
STT icon
State Street
STT
+$1.29B

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 17.53%
3 Financials 14.18%
4 Consumer Discretionary 14.02%
5 Communication Services 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBK
2551
DELISTED
Christopher & Banks Corporation
CBK
$6K ﹤0.01%
12,512
MTCH icon
2552
PUT
Match Group
MTCH
$8.4B
$4K ﹤0.01%
100
ICON
2553
DELISTED
Iconix Brand Group, Inc.
ICON
$2K ﹤0.01%
2,530
-13,720
-84% -$24.2K
ABUS icon
2554
Arbutus Biopharma
ABUS
$907M
-497,328
Closed -$4.7M
AER icon
2555
AerCap
AER
$23.6B
-4,907
Closed -$282K
APAM icon
2556
Artisan Partners
APAM
$2.97B
-8,775
Closed -$284K
ASMB icon
2557
Assembly Biosciences
ASMB
$536M
-18,525
Closed -$8.26M
ATEN icon
2558
A10 Networks
ATEN
$2B
-25,673
Closed -$156K
AXDX
2559
DELISTED
Accelerate Diagnostics
AXDX
-958
Closed -$220K
BCE icon
2560
BCE
BCE
$21.6B
-9,790
Closed -$397K
BGFV
2561
DELISTED
Big 5 Sporting Goods
BGFV
-99,536
Closed -$508K
BJRI icon
2562
BJ's Restaurants
BJRI
$1.48B
-3,772
Closed -$272K
BV icon
2563
BrightView Holdings
BV
$1.08B
-2,427,537
Closed -$39M
CMCO icon
2564
Columbus McKinnon
CMCO
$557M
-6,453
Closed -$255K
CMCM
2565
Cheetah Mobile
CMCM
$93.7M
-16,789
Closed -$825K
CNXN icon
2566
PC Connection
CNXN
$2.03B
-5,334
Closed -$207K
COOP
2567
DELISTED
Mr. Cooper
COOP
-6,814
Closed -$114K
CUBI icon
2568
Customers Bancorp
CUBI
$2.8B
-9,541
Closed -$224K
DAKT icon
2569
Daktronics
DAKT
$997M
-32,908
Closed -$258K
DOMO icon
2570
Domo
DOMO
$184M
-242,029
Closed -$4.93M
CHRN
2571
ChronoScale Holdings
CHRN
$3.02B
-144
Closed -$76K
EPOL icon
2572
iShares MSCI Poland ETF
EPOL
$825M
-75,000
Closed -$1.79M
GTES icon
2573
Gates Industrial Corporation Ltd.
GTES
$7.05B
-16,386
Closed -$320K
LEN.B icon
2574
Lennar Class B
LEN.B
$20.1B
-26,333
Closed -$964K
LPSN icon
2575
LivePerson
LPSN
$34.1M
-530
Closed -$206K

Similar funds

T. Rowe Price Associates's Q4 2018 Portfolio in Review

As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
  • T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
  • T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
  • T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
  • T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
  • T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.